NanoString Technologies Inc at JPMorgan Healthcare Conference Transcript

Jan 10, 2024 / 10:15PM GMT
Rachel Vatnsdal J.P. Morgan Securities plc-Analyst

Good afternoon, everyone. This is Rachel Vatnsdal with the life science tools and diagnostics team. I'm joined today by the NanoString management team. This will be a 40-minute session with 20 Minutes give or take of a presentation followed by some Q&A. If any of you in the room do have questions, please feel free to e-mail them to me. Otherwise, you can submit them in the portal.

And with that, I will pass it off to Brad.

R. Bradley Gray - NanoString Technologies Inc - President, Chief Executive Officer, Director

Thanks, Rachel. I appreciate everybody coming to this afternoon. I want to do three things today. I want to first provide an overview of NanoString for those of you who might be new to the story. The second is I want to recap how we did on our strategic objectives in 2023. And the third thing I want to do is lay out the catalysts that we see ahead for 2024.

I will be making forward-looking statements and would refer you to our SEC filings and particularly the risk factors

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot